
Current Market Outlook
Following last week’s rolling crash in the market, everyone is wondering what comes next, but instead of predicting (guessing), it’s better to stick with the facts. Here’s where the evidence stands: The intermediate-term trend is clearly down for all major indexes and most (though not all) stocks, and given that this comes after a prolonged advance, some time is likely going to be needed to repair the damage. Short-term, though, we did see some legitimate extremes in a few key measures (900-plus new lows on the NYSE on Friday; just 3% of S&P 500 stocks above their 50-day line; record SPY volume on Friday) that says today’s bounce could go further. All together, it’s best to be in a cautious stance (holding cash, limiting new buying, pruning your worst performers), though you shouldn’t panic out of everything—holding on to your resilient winners is fine, and if you have plenty of cash, a little buying is fine as well.
This week’s list is a good place to start building your watch list (or, if you’re in the buying mood, looking for candidates to nibble on). Our Top Pick is
Regeneron Pharmaceuticals (REGN), which has a good overall story and what could be a big catalyst, too. Aim for dips.
| Stock Name | Price | Buy Range | Loss Limit |
|---|
| Atlassian (TEAM) | 182.16 | 142-146 | 131-133 |
| Bill.com Holdings (BILL) | 88.76 | 55-58 | 47.5-49 |
| Cloudflare (NET) | 39.32 | 20.5-21.5 | 18-18.5 |
| Datadog (DDOG) | 81.52 | 42.5-44.5 | 39-40.5 |
| Dexcom (DXCM) | 421.36 | 267-277 | 239-242 |
| Enphase Energy (ENPH) | 46.70 | 48.5-51.5 | 42.5-43.5 |
| Regeneron Pharmaceuticals (REGN) | 512.96 | 435-455 | 390-400 |
| RingCentral (RNG) | 238.73 | 223-231 | 202-206 |
| Seattle Genetics (SGEN) | 150.85 | 107-111 | 98-101 |
| Square, Inc. (SQ) | 91.04 | 78-81 | 71-73 |